2008
DOI: 10.1001/archneur.65.11.1454
|View full text |Cite
|
Sign up to set email alerts
|

Magnetization Transfer Ratio in Gray Matter

Abstract: Background: Magnetization transfer imaging has the potential to provide a surrogate marker for progression in primary progressive multiple sclerosis (PPMS). Objectives: To investigate whether brain magnetization transfer imaging, T2 lesion load, and atrophy changes over 3 years reflect concurrent clinical changes, and which baseline imaging measure best predicts progression over 3 years in early PPMS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
10
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 57 publications
(11 citation statements)
references
References 34 publications
(41 reference statements)
1
10
0
Order By: Relevance
“…23 Wallerian degeneration, both anterograde and retrograde, secondary to proximal and/or distal axonal damage has also been implicated as a mechanism contributing to lower MTR in the gray matter. 24,64 The strong afferent and efferent connectivity of the caudate makes this another credible neurobiological explanation for our finding. The relative contributions of these mechanisms to the MTR may vary across disease states.…”
Section: Discussionsupporting
confidence: 53%
“…23 Wallerian degeneration, both anterograde and retrograde, secondary to proximal and/or distal axonal damage has also been implicated as a mechanism contributing to lower MTR in the gray matter. 24,64 The strong afferent and efferent connectivity of the caudate makes this another credible neurobiological explanation for our finding. The relative contributions of these mechanisms to the MTR may vary across disease states.…”
Section: Discussionsupporting
confidence: 53%
“…Recent observations suggest that GM is involved in an inflammatory demyelination process in early MS (Inglese et al, 2011; Khaleeli et al, 2008; Lucchinetti et al, 2011). However, no evidence was observed to confirm the change in tight junctions within the BBB in the GM of patients with MS (van Horssen et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…Although GM atrophy and lesion load are known to be good predictors of clinical disability and clinical outcome (Charil et al, 2007; Khaleeli et al, 2008), the causal relationship between these two surrogate markers is still uncertain (Chard and Miller, 2009; Miller et al, 2002). Mapping the topography of cortical lesions and atrophy across time could potentially provide new insights into the interaction of these two markers (Mainero et al, 2010).…”
Section: Discussionmentioning
confidence: 99%